Treatment of rituximab in patients with idiopathic membranous nephropathy: a case series and literature review

Treatment of rituximab in patients with idiopathic membranous nephropathy: a case series and literature review

Background/Aims Membranous nephropathy (MN) is a major cause of nephrotic syndrome in adults. This study aimed to evaluate the effect of rituximab (RTX) in patients with idiopathic MN (iMN) who have a high risk of progression. Methods We retrospectively analyzed data of 13 patients with iMN, who rec...

Full description

Bibliographic Details
Main Authors: Soo-Jee Jeon, Ji-Hye Kim, Hee-Won Noh, Ga-Young Lee, Jeong-Hoon Lim, Hee-Yeon Jung, Jang-Hee Cho, Ji-Young Choi, Chan-Duck Kim, Yong-Lim Kim, Sun-Hee Park
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2022-07-01
Series:The Korean Journal of Internal Medicine
Subjects:
rituximab
glomerulonephritis
membranous
proteinuria
nephrotic syndrome
immunosuppressive agents
Online Access:http://kjim.org/upload/pdf/kjim-2021-155.pdf

Internet

http://kjim.org/upload/pdf/kjim-2021-155.pdf

Similar Items